The last unresolved governor's race of 2016 is over. N.C. Gov. Pat McCrory has conceded to Democrat Roy Cooper after a closely fought race in one of the country's most politically divided states.
President-elect Donald Trump's telephone conversation with Taiwan's president broke four decades of diplomatic protocol. There's concern it could also spark a crisis with China, which considers Taiwan a renegade province.
NPR's Ari Shapiro talks with Amy Liu, director of the Metropolitan Policy Program at the Brookings Institution who worked at the Department of Housing and Urban Development during the Clinton administration, about President-elect Donald Trump's nomination of Dr. Ben Carson to run the agency.
In Washington, D.C., local businesses are asking for more security after an armed man threatened a pizza place targeted by fake news stories. Police say the North Carolina man wanted to investigate a conspiracy theory that Hillary Clinton runs a child sex ring from the restaurant.
A judge in South Carolina declared a mistrial in the police shooting case of Michael Slager. Slager was video taped shooting Walter Scott after he fled a traffic stop. Jurors deadlocked on Slager's guilt.
Pipeline opponents are celebrating Sunday's decision by the Army Corps of Engineers to not approve a key part of the Dakota Access Pipeline. Protesters fear the decision will be reversed by the incoming Trump administration.
Yale has announced a new procedure for considering the renaming of university buildings, which could allow for the renaming of Calhoun College. NPR's Audie Cornish talks to Jonathan Holloway, dean of Yale College, about the new procedure.
Following Donald Trump's election, the University of California system has announced it will not cooperate with federal immigration authorities or turn over records to the government regarding students in the country illegally. NPR's Audie Cornish talks to Janet Napolitano, president of the University of California and former secretary of Homeland Security.
A gene-editing technology called CRISPR-cas9 could be a gold mine for its inventors, but it's not clear who owns the idea. U.S. patent judges will soon hear oral arguments to decide the issue.